These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 17626752)

  • 1. [Clinical significance of the proportion of CD4+CD25+ regulatory T cells in peripheral blood of hepatocellular carcinoma patients: a report of 117 cases].
    Peng QQ; Li SP; Xu L; Li JQ
    Ai Zheng; 2007 Jul; 26(7):748-51. PubMed ID: 17626752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of regulatory T cells proportion in the peripheral blood and tumor tissue in primary hepatocellular carcinoma].
    Li SP; Peng QQ; Ding T; Xu J; Zhang CQ; Feng KT; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):523-7. PubMed ID: 19062720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients.
    Li F; Guo Z; Lizée G; Yu H; Wang H; Si T
    Clin Chem Lab Med; 2014 Sep; 52(9):1357-65. PubMed ID: 24646790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of peripheral and intratumoral regulatory T-cells in hepatocellular carcinoma: a case-control study.
    Thakur S; Singla A; Chawla Y; Rajwanshi A; Kalra N; Arora SK
    Indian J Pathol Microbiol; 2011; 54(3):448-53. PubMed ID: 21934201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
    Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The presence and the significance of CD4+CD25+ regulatory T cells in livers of patients with hepatocellular carcinoma].
    Yang XH; Liu BR; Jiang HC
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):279-82. PubMed ID: 17456316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.
    Yang XH; Yamagiwa S; Ichida T; Matsuda Y; Sugahara S; Watanabe H; Sato Y; Abo T; Horwitz DA; Aoyagi Y
    J Hepatol; 2006 Aug; 45(2):254-62. PubMed ID: 16600416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma.
    Shen X; Li N; Li H; Zhang T; Wang F; Li Q
    J Cancer Res Clin Oncol; 2010 Nov; 136(11):1745-54. PubMed ID: 20221638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of CD4+ CD25+ regulatory T cells in chronic hepatitis B patients].
    Zhang HH; Guo F; Fei R; Ma H; Cong X; Wei L; Chen HS
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):511-5. PubMed ID: 18649763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of serum and soluble CD25 (sCD25) on regulatory and effector T-cell function in hepatocellular carcinoma.
    Cabrera R; Ararat M; Eksioglu EA; Cao M; Xu Y; Wasserfall C; Atkinson MA; Liu C; Nelson DR
    Scand J Immunol; 2010 Oct; 72(4):293-301. PubMed ID: 20883314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
    Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J
    BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD4+CD25+CD127
    Zhou W; Deng J; Chen Q; Li R; Xu X; Guan Y; Li W; Xiong X; Li H; Li J; Cai X
    Int J Med Sci; 2020; 17(6):712-719. PubMed ID: 32218692
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibiting effect of Astragalus polysaccharides on the functions of CD4+CD25 highTreg cells in the tumor microenvironment of human hepatocellular carcinoma.
    Li Q; Bao JM; Li XL; Zhang T; Shen XH
    Chin Med J (Engl); 2012 Mar; 125(5):786-93. PubMed ID: 22490576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of transcatheter arterial chemoembolization on cellular immune function and regulatory T cells in patients with hepatocellular carcinoma.
    Liao J; Xiao J; Zhou Y; Liu Z; Wang C
    Mol Med Rep; 2015 Oct; 12(4):6065-71. PubMed ID: 26239573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the Peripheral Blood Treg Cell Proportion in Hepatocellular Carcinoma Patients After Transarterial Chemoembolization With Microparticles.
    Ren Z; Yue Y; Zhang Y; Dong J; Liu Y; Yang X; Lin X; Zhao X; Wei Z; Zheng Y; Wang T
    Front Immunol; 2021; 12():624789. PubMed ID: 33717135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of regulatory T cell number in hepatocellular carcinoma-bearing mice and its relationship with tumor growth].
    Zhang P; Zhang LN; Zhu FL; Wang Q; Wang XY; Li HY; Liu CM; Gao F; Liu CH
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):342-5. PubMed ID: 17892128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis.
    Lewkowicz N; Lewkowicz P; Dzitko K; Kur B; Tarkowski M; Kurnatowska A; Tchórzewski H
    J Oral Pathol Med; 2008 Sep; 37(8):454-61. PubMed ID: 18318707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.